Corrections:
Correction: MiR-451 as a new tumor marker for gastric cancer
Metrics: PDF 1359 views | ?
1 Department of Pathology and Pathophysiology, Medical School of Southeast University, Nanjing, Jiangsu, China
2 Department of Clinical Laboratory, Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, Henan, China
3 Department of Clinical Laboratory, The Second Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China
4 Department of Hepatobiliary Surgery, Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, Henan, China
Published: October 29, 2019
This article has been corrected: The authors' affiliation information was listed incorrectly. The proper affiliations are as follows:
1 Department of Pathology and Pathophysiology, Medical School of Southeast University, Nanjing, Jiangsu, China
2 Department of Clinical Laboratory, Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, Henan, China
3 Department of Clinical Laboratory, The Second Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China
4 Department of Hepatobiliary Surgery, Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, Henan, China
Original article: Oncotarget. 2017; 8:56542–56545. DOI: https://doi.org/10.18632/oncotarget.17239.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 27291